Trials / Terminated
TerminatedNCT01476631
Step Down Colon Cancer Risk
Step Down Colon Cancer Risk: A Pilot Intervention for Colon Cancer Risk Reduction
- Status
- Terminated
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 17 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
Hypothesis 1: Exercise will decrease serum markers in a dose response manner. Hypothesis 2: Participants in the 60 minute intervention will have significantly higher physical activity levels than those in the 30 minute intervention at three months.
Detailed description
Primary Aim: To conduct a dose response pilot trial of low (30 min/day) or high (60 min/day) dose exercise in men and women at increased risk of colon cancer. The major outcomes are changes in serum levels of four risk-related biomarkers: insulin, C-peptide, IL-6 and PGE-2. Secondary Aim. To compare changes in the secondary outcome of physical activity over three months.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Walking | * 7 days prior to baseline participants must wear a blinded pedometer * At baseline information on the blinded pedometer will downloaded to the computer for analysis as well as number of days worn and hours of wear. Sociodemographic, cancer risk factors, height/weight, fast blood draw to check levels on insulin, C-peptide, IL-6 and PEG-2 and questionnaires PPAQ, Exercise Confident Survey and Sallis Social Support Scale, Day/night; Home/Work, neighborhood safety, HINTS, IPAPS, CES-D, Brief COPE, Urban and Life Stress Scale. |
Timeline
- Start date
- 2008-11-01
- Primary completion
- 2010-04-01
- Completion
- 2010-04-01
- First posted
- 2011-11-22
- Last updated
- 2013-08-05
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01476631. Inclusion in this directory is not an endorsement.